Authors
Loading...
Biochemical study reveals that nonactive-site residues govern catalytic efficiency in OXA-232 carbapenemase, highlighting new targets for overcoming antibiotic resistance.
Tejavath et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: